CAR-BCMA T cells
CG6003
Phase 1 gene_therapy active
Quick answer
CAR-BCMA T cells for Refractory or Relapsed Multiple Myeloma is a Phase 1 program (gene_therapy) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Refractory or Relapsed Multiple Myeloma
- Phase
- Phase 1
- Modality
- gene_therapy
- Status
- active